Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    February 2017
  1. CHEN QZ, Li Y, Shao Y, Zeng YH, et al
    TGF-beta1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells.
    Int J Oncol. 2017 Feb 13. doi: 10.3892/ijo.2017.3875.
    PubMed     Text format     Abstract available


  2. LU CC, Chu PY, Hsia SM, Wu CH, et al
    Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells.
    Int J Oncol. 2017;50:736-744.
    PubMed     Text format     Abstract available


    December 2016
  3. KAWAI K, Uemura M, Munakata K, Takahashi H, et al
    Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3814.
    PubMed     Text format     Abstract available


  4. HATA T, Mokutani Y, Takahashi H, Inoue A, et al
    Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3813.
    PubMed     Text format     Abstract available


  5. YU H, Zhang H, Dong M, Wu Z, et al
    Metabolic reprogramming and AMPKalpha1 pathway activation by caulerpin in colorectal cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3794.
    PubMed     Text format     Abstract available


    November 2016
  6. HAGGBLAD SAHLBERG S, Mortensen AC, Haglof J, Engskog MK, et al
    Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
    Int J Oncol. 2016 Nov 18. doi: 10.3892/ijo.2016.3771.
    PubMed     Text format     Abstract available


    October 2016
  7. EL KHOURY F, Corcos L, Durand S, Simon B, et al
    Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    Int J Oncol. 2016 Oct 7. doi: 10.3892/ijo.2016.3725.
    PubMed     Text format     Abstract available


  8. GAO B, Shao Q, Choudhry H, Marcus V, et al
    [Corrigendum] Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016 Oct 6. doi: 10.3892/ijo.2016.3722.
    PubMed     Text format     Abstract available


    September 2016
  9. YAMAMOTO H, Oshiro R, Ohtsuka M, Uemura M, et al
    [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
    Int J Oncol. 2016 Sep 16. doi: 10.3892/ijo.2016.3694.
    PubMed     Text format     Abstract available


  10. PARK GB, Chung YH, Gong JH, Jin DH, et al
    GSK-3beta-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
    Int J Oncol. 2016 Sep 5. doi: 10.3892/ijo.2016.3679.
    PubMed     Text format     Abstract available


  11. LIANG F, Li Q, Li X, Li Z, et al
    TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer.
    Int J Oncol. 2016;49:1046-56.
    PubMed     Text format     Abstract available


  12. GAO B, Shao Q, Choudhry H, Marcus V, et al
    Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016;49:1108-18.
    PubMed     Text format     Abstract available


    August 2016
  13. WANG W, Liu J, Qi J, Zhang J, et al
    Downregulation of RLIP76 is associated with vincristine resistance in human colorectal cancer HCT-8/VCR cells.
    Int J Oncol. 2016 Aug 23. doi: 10.3892/ijo.2016.3672.
    PubMed     Text format     Abstract available


    July 2016
  14. XIAO Y, Zheng X, Huang A, Liu T, et al
    Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer.
    Int J Oncol. 2016 Jul 25. doi: 10.3892/ijo.2016.3629.
    PubMed     Text format     Abstract available


    June 2016
  15. KIM GT, Lee SH, Kim YM
    Torilis japonica extract-generated intracellular ROS induces apoptosis by reducing the mitochondrial membrane potential via regulation of the AMPK-p38 MAPK signaling pathway in HCT116 colon cancer.
    Int J Oncol. 2016 Jun 16. doi: 10.3892/ijo.2016.3578.
    PubMed     Text format     Abstract available


  16. LIN CL, Hsieh SL, Leung W, Jeng JH, et al
    2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside suppresses human colorectal cancer cell metastasis through inhibiting NF-kappaB activation.
    Int J Oncol. 2016 Jun 9. doi: 10.3892/ijo.2016.3574.
    PubMed     Text format     Abstract available


  17. LU M, Wang C, Wang J
    Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3565.
    PubMed     Text format     Abstract available


  18. ESPOSITO G, Gigli S, Seguella L, Nobile N, et al
    Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3550.
    PubMed     Text format     Abstract available


  19. GALATEANU B, Hudita A, Negrei C, Ion RM, et al
    Impact of multicellular tumor spheroids as an in vivolike tumor model on anticancer drug response.
    Int J Oncol. 2016;48:2295-302.
    PubMed     Text format     Abstract available


  20. ORLANDO A, Linsalata M, Russo F
    Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG.
    Int J Oncol. 2016;48:2629-38.
    PubMed     Text format     Abstract available


    April 2016
  21. BASAK D, Punganuru SR, Srivenugopal KS
    Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.
    Int J Oncol. 2016;48:1426-36.
    PubMed     Text format     Abstract available


    March 2016
  22. YUAN Z, Yu X, Ni B, Chen D, et al
    Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/beta-catenin signaling and predicts favorable prognosis.
    Int J Oncol. 2016 Mar 21. doi: 10.3892/ijo.2016.3447.
    PubMed     Text format     Abstract available


  23. PARK YR, Lee ST, Kim SL, Liu YC, et al
    MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Int J Oncol. 2016 Mar 9. doi: 10.3892/ijo.2016.3430.
    PubMed     Text format     Abstract available


  24. ZHAO LD, Zheng WW, Wang GX, Kang XC, et al
    Epigenetic silencing of miR-181b contributes to tumorigenicity in colorectal cancer by targeting RASSF1A.
    Int J Oncol. 2016 Mar 3. doi: 10.3892/ijo.2016.3414.
    PubMed     Text format     Abstract available


    February 2016
  25. CHEN S, Chen W, Zhang X, Lin S, et al
    Overexpression of KiSS-1 reduces colorectal cancer cell invasion by downregulating MMP-9 via blocking PI3K/Akt/NF-kappaB signal pathway.
    Int J Oncol. 2016 Feb 2. doi: 10.3892/ijo.2016.3368.
    PubMed     Text format     Abstract available


  26. CHEN J, Wei Y, Feng Q, Ren L, et al
    Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway.
    Int J Oncol. 2016 Feb 1. doi: 10.3892/ijo.2016.3366.
    PubMed     Text format     Abstract available


  27. YOSHIOKA S, Mitsuyama K, Takedatsu H, Kuwaki K, et al
    Advanced endoscopic features of ulcerative colitis-associated neoplasias: Quantification of autofluorescence imaging.
    Int J Oncol. 2016;48:551-8.
    PubMed     Text format     Abstract available


  28. WOJAS-TUREK J, Szczygiel A, Kicielinska J, Rossowska J, et al
    Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4(+) T cell response against MC38 colon carcinoma.
    Int J Oncol. 2016;48:493-505.
    PubMed     Text format     Abstract available


    January 2016
  29. YOSHII Y, Furukawa T, Aoyama H, Adachi N, et al
    Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
    Int J Oncol. 2016 Jan 28. doi: 10.3892/ijo.2016.3361.
    PubMed     Text format     Abstract available


  30. WU X, Luo F, Li J, Zhong X, et al
    Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.
    Int J Oncol. 2016 Jan 26. doi: 10.3892/ijo.2016.3360.
    PubMed     Text format     Abstract available


  31. DENG JJ, Zhang W, Xu XM, Zhang F, et al
    Twist mediates an aggressive phenotype in human colorectal cancer cells.
    Int J Oncol. 2016 Jan 15. doi: 10.3892/ijo.2016.3342.
    PubMed     Text format     Abstract available


  32. ZHAO H, Yu H, Martin TA, Zhang Y, et al
    Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer.
    Int J Oncol. 2016 Jan 15. doi: 10.3892/ijo.2016.3340.
    PubMed     Text format     Abstract available


  33. IKAI A, Watanabe M, Sowa Y, Kishimoto M, et al
    Phosphorylated retinoblastoma protein is a potential predictive marker of irinotecan efficacy for colorectal cancer.
    Int J Oncol. 2016 Jan 12. doi: 10.3892/ijo.2016.3332.
    PubMed     Text format     Abstract available


  34. MASUDA T, Ishikawa T, Mogushi K, Okazaki S, et al
    Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.
    Int J Oncol. 2016 Jan 11. doi: 10.3892/ijo.2016.3329.
    PubMed     Text format     Abstract available


  35. CHIAPPA A, Bertani E, Zbar AP, Foschi D, et al
    Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?
    Int J Oncol. 2016 Jan 5. doi: 10.3892/ijo.2016.3324.
    PubMed     Text format     Abstract available


  36. TAKAHASHI H, Suzuki Y, Nishimura J, Haraguchi N, et al
    Characteristics of carbonic anhydrase 9 expressing cells in human intestinal crypt base.
    Int J Oncol. 2016;48:115-22.
    PubMed     Text format     Abstract available


    December 2015
  37. IZUTANI Y, Yogosawa S, Sowa Y, Sakai T, et al
    [Corrigendum] Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells.
    Int J Oncol. 2015 Dec 30. doi: 10.3892/ijo.2015.3315.
    PubMed     Text format     Abstract available


  38. JEONG D, Park S, Kim H, Kim CJ, et al
    RhoA is associated with invasion and poor prognosis in colorectal cancer.
    Int J Oncol. 2015 Dec 8. doi: 10.3892/ijo.2015.3281.
    PubMed     Text format     Abstract available


    November 2015
  39. REN Z, Wang W, Li J
    Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
    Int J Oncol. 2015 Nov 24. doi: 10.3892/ijo.2015.3263.
    PubMed     Text format     Abstract available


  40. CHIBA M, Watanabe N, Watanabe M, Sakamoto M, et al
    Exosomes derived from SW480 colorectal cancer cells promote cell migration in HepG2 hepatocellular cancer cells via the mitogen-activated protein kinase pathway.
    Int J Oncol. 2015 Nov 19. doi: 10.3892/ijo.2015.3255.
    PubMed     Text format     Abstract available


  41. HAN J, Meng Q, Xi Q, Zhang Y, et al
    Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer.
    Int J Oncol. 2015 Nov 2. doi: 10.3892/ijo.2015.3225.
    PubMed     Text format     Abstract available


    September 2015
  42. FUNAMIZU N, Lacy CR, Kamada M, Yanaga K, et al
    MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells.
    Int J Oncol. 2015 Sep 22. doi: 10.3892/ijo.2015.3178.
    PubMed     Text format     Abstract available


    July 2015
  43. ROOMI MW, Kalinovsky T, Niedzwiecki A, Rath M, et al
    Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines.
    Int J Oncol. 2015;47:370-6.
    PubMed     Text format     Abstract available


  44. STEINMANN S, Scheibe K, Erlenbach-Wuensch K, Neufert C, et al
    Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review).
    Int J Oncol. 2015;47:5-15.
    PubMed     Text format     Abstract available


    April 2015
  45. SUN H, Pan Y, He B, Deng Q, et al
    Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting.
    Int J Oncol. 2015;46:1759-67.
    PubMed     Text format     Abstract available


    January 2015
  46. SAKAMOTO K, Yokogawa T, Ueno H, Oguchi K, et al
    Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.
    Int J Oncol. 2015;46:2327-34.
    PubMed     Text format     Abstract available


  47. HYUN HB, Lee WS, Go SI, Nagappan A, et al
    The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells.
    Int J Oncol. 2015;46:2670-8.
    PubMed     Text format     Abstract available


  48. HA BG, Park JE, Cho HJ, Lim YB, et al
    Inhibitory effects of proton beam irradiation on integrin expression and signaling pathway in human colon carcinoma HT29 cells.
    Int J Oncol. 2015;46:2621-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: